logo
Liverpool could sign two of the most expensive players EVER

Liverpool could sign two of the most expensive players EVER

Yahoo7 hours ago

Liverpool could sign two of the most expensive players EVER
Liverpool have signed Wirtz, Isak next?
Any deal done for the Swede is not going to be easy. Isak is one of the best forwards in the world and is under contract until 2028.
In an item discussing Liverpool's reported interest in the Geordie hitman, the Telegraph reveals that no discussions have yet been opened over Isak.
Advertisement
With focus on Wirtz up until his unveiling on Friday, Liverpool have not yet made an approach for the former Borussia Dortmund forward.
Moreover it's claimed that Liverpool wouldn't just have to beat their newly-set club transfer record for Wirtz - they will have to come very close to breaking the world transfer record if they have any chance of talking Newcastle into a sale.
© IMAGO - Florian Wirtz Liverpool
Newcastle want deal approaching £200m for Isak
'We are not just talking about a British record transfer fee, we are looking at something approaching the £200 million world record Paris St-Germain paid to sign Neymar from Barcelona,' the report states.
Advertisement
PSG currently own the records for the two most expensive transfers of all time (€).
Wirtz has just become the seventh-most expensive player of all time having moved from Bayer Leverkusen - potentially rising to fourth just behind Philippe Coutinho - if all add-ons are met.
Coutinho swapped Liverpool for Barcelona in a €145m deal back in January 2018 - allowing Liverpool to plough the proceeds into Virgil van Dijk and Alisson Becker.
Wirtz could end up topping out at €137.5m.
© IMAGO
Liverpool tipped to break records in transfer market
Liverpool will potentially end up with TWO of the most expensive players of all time - assuming Isak's price actually beats the Wirtz fee.
Advertisement
In fact, it's likely to come closer to the €180m PSG paid to Monaco for Mbappe in 2018.
Mbappe, second on the list after Neymar, initially moved on loan from Monaco in 2017 before the deal was made permanent a year later.
These deals will signal a shift in transfer market power in Liverpool's favour. Liverpool's careful financial planning under FSG is set to be rewarded in record-breaking fashion.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

McAtee nets opener as England beat Spain to reach U21 Euros semi-finals
McAtee nets opener as England beat Spain to reach U21 Euros semi-finals

Yahoo

time38 minutes ago

  • Yahoo

McAtee nets opener as England beat Spain to reach U21 Euros semi-finals

James McAtee scored the first goal of the game as England beat Spain 3-1 in the quarter-finals of the 2025 U21 European Championships in Slovakia. Captaining Lee Carsley's side, McAtee pounced on a loose ball to turn home from a few yards out after just 10 minutes. Advertisement That was backed up shortly after by Harvey Elliott, who made the most of a tap in after a low shot was spilled by goalkeeper Alejandro Iturbe. Spain were given a lifeline as half-time approached when Jarrell Quansah tripped Alberto Moleiro in the box. Valencia's Javi Guerra made no mistake from the spot, halving England's lead at the break. With England working hard to keep Spain at arm's length in the second period, McAtee - a creative midfielder who shines on the ball - ran himself into the ground. Our Academy graduate was replaced in the 71st minute as Carsley sought to reinforce further back. Advertisement England held firm and were even able to make the game safe in stoppage time, when Jonathan Rowe was felled by Iturbe in the box. Nottingham Forest's Elliot Anderson converted for the defending champions to ensure safe progress. Speaking after the game, McAtee was only focused on what's to come. "We're over the moon but the focus is the semi-final now," he said. "We got through the group but we knew it wasn't good enough so we had to step it up today so we're glad we got the win." McAtee and England will now face Netherlands at the Slovakian national stadium in Bratislava at 17:00 (UK) on Wednesday 25 June for a place in the final. We'll have a report from that game on and our official app shortly after it concludes.

Piper Sandler Reaffirms Overweight Rating on Soleno (SLNO) Driven by Strong VYKAT XR Prospects
Piper Sandler Reaffirms Overweight Rating on Soleno (SLNO) Driven by Strong VYKAT XR Prospects

Yahoo

time42 minutes ago

  • Yahoo

Piper Sandler Reaffirms Overweight Rating on Soleno (SLNO) Driven by Strong VYKAT XR Prospects

Soleno Therapeutics Inc. (NASDAQ:SLNO) is one of the 10 biotech stocks screaming a buy now. On June 17, Piper Sandler reiterated an 'Overweight' rating on the stock with a $145 price target. The bullish stance follows positive discussions with a European specialist on the company's VYKAT XR medication for Prader-Willi syndrome (PWS). A scientist in a laboratory examining a microscope in the pursuit of cell therapy discoveries. Piper Sandler consulted a UK-based pediatric endocrinologist to understand the drug better. The specialist indicated she would prescribe the drug as medication for Prader-Willi syndrome (PWS) to all eligible patients upon approval. Soleno Therapeutics' edge with the drug stems from the fact that other PWS treatments are in the early stages of development. Piper Sandler believes VYKAT XT represents significant potential as the first approved treatment specifically addressing PWS, a condition. The biotech company plans to file a Marketing Authorization Application for VYKAT XR in the second quarter. It's also pursuing regulatory approval in Europe as it plans to fill with the European Medicines agency. Following regulatory approvals, Soleno Therapeutics Palms will launch the drug in the first quarter of 2026. Soleno Therapeutics is a biopharmaceutical company that develops and commercializes novel treatments for rare diseases. Their lead product, diazoxide choline extended-release tablets (DCCR), is being developed for Prader-Willi syndrome (PWS), specifically to address hyperphagia (excessive hunger). While we acknowledge the potential of SLNO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Best Software Stocks to Buy Now and 11 Must-Buy AI Stocks Analysts Are Betting On. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store